ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
65,696.98
1.12%
S&P 500
5,487.03
0.25%
Dow Jones
38,834.86
0.15%
US Dollar vs Yen
158.4155
0.29%
Brent Oil
84.64
-0.06%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Celator Pharmaceuticals Inc. (MM) (CPXX)

  7. Celator Pharmaceuticals Inc. (MM) (CPXX) ニュース

CPXX

Celator Pharmaceuticals Inc. (CPXX)

Celator Pharmaceuticals Inc. (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CPXX
日付受信時刻ニュースソース見出しコード企業名
2018/02/1405 : 59Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2017/02/1605 : 12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2017/02/1423 : 02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2017/01/3106 : 40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/08/0305 : 02Edgar (US Regulatory)Amended Termination of Registration of a Class of Security Under Section 12(b) (15-12b/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/08/0219 : 02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/2806 : 50Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/2619 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/2300 : 30Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1605 : 50Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1402 : 07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1306 : 09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1306 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1306 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 15Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 12Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 10Edgar (US Regulatory)Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 06Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1305 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1222 : 14Edgar (US Regulatory)(25-NSE)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1221 : 43Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
2016/07/1221 : 41Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:CPXX

最近閲覧した銘柄

NASDAQ
NVDA
NVIDIA
USOTC
RHHBY
Roche (QX)
USI
USTECH100
US Tech 100
NYSE
DIS
Walt Disney
NYSE
AXP
American Express
CCOM
US30
US 30
SPI
SP500
S&P 500
AMEX
XLV
Health Care Select Sector
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
MSFT
Microsoft
AMEX
XLF
Financial Select Sector
NYSE
MRK
Merck
NYSE
BAC
Bank of America
NYSE
CVX
Chevron
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有